Company Overview: Botanix Pharmaceuticals Limited (ASX: BOT) is an ASX-listed clinical-stage medical dermatology company focused on developing topical treatments for skin conditions like acne, psoriasis, and excessive sweating. This Report covers the Price Action, Technical Indicators Analysis along with the Support Levels, Resistance Levels, and Recommendations on this stock.
From a technical perspective, BOT continues to exhibit a constructive chart structure, with the share price holding firmly above a key falling trendline support, reflecting sustained buying interest and reinforcing the prevailing bullish outlook. Momentum remains supportive, with the 14-period Relative Strength Index (RSI) recovering to 62.23, indicating…
